Axxcess Wealth Management LLC Sells 2,421 Shares of Zoetis Inc. (NYSE:ZTS)

Axxcess Wealth Management LLC cut its position in Zoetis Inc. (NYSE:ZTS) by 60.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,576 shares of the company’s stock after selling 2,421 shares during the period. Axxcess Wealth Management LLC’s holdings in Zoetis were worth $257,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of ZTS. Howard Capital Management Group LLC raised its holdings in Zoetis by 0.8% in the third quarter. Howard Capital Management Group LLC now owns 104,866 shares of the company’s stock worth $20,489,000 after purchasing an additional 883 shares during the period. Principal Financial Group Inc. raised its holdings in Zoetis by 17.3% in the third quarter. Principal Financial Group Inc. now owns 2,377,403 shares of the company’s stock worth $464,497,000 after purchasing an additional 351,372 shares during the period. Advisors Asset Management Inc. raised its holdings in Zoetis by 2.3% in the third quarter. Advisors Asset Management Inc. now owns 17,520 shares of the company’s stock worth $3,423,000 after purchasing an additional 388 shares during the period. Landscape Capital Management L.L.C. acquired a new stake in Zoetis in the third quarter worth $458,000. Finally, Pacer Advisors Inc. raised its holdings in Zoetis by 15.4% in the third quarter. Pacer Advisors Inc. now owns 46,611 shares of the company’s stock worth $9,107,000 after purchasing an additional 6,237 shares during the period. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on ZTS. Piper Sandler raised their price objective on shares of Zoetis from $200.00 to $205.00 and gave the stock an “overweight” rating in a report on Thursday, February 27th. Stifel Nicolaus dropped their price objective on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. Leerink Partnrs upgraded shares of Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. Leerink Partners began coverage on shares of Zoetis in a report on Monday, December 2nd. They set an “outperform” rating and a $215.00 price objective on the stock. Finally, StockNews.com upgraded shares of Zoetis from a “hold” rating to a “buy” rating in a report on Friday, March 7th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, Zoetis presently has an average rating of “Buy” and a consensus price target of $215.90.

Zoetis Stock Down 0.2 %

Shares of ZTS stock opened at $162.86 on Friday. The company has a current ratio of 1.75, a quick ratio of 1.08 and a debt-to-equity ratio of 1.09. Zoetis Inc. has a 1 year low of $144.80 and a 1 year high of $200.33. The firm’s fifty day moving average price is $166.76 and its two-hundred day moving average price is $175.47. The firm has a market capitalization of $72.93 billion, a P/E ratio of 29.77, a PEG ratio of 2.78 and a beta of 0.94.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.40 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. Zoetis had a net margin of 26.86% and a return on equity of 53.82%. The company had revenue of $2.32 billion during the quarter, compared to the consensus estimate of $2.30 billion. On average, equities analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.23%. The ex-dividend date of this dividend is Monday, April 21st. Zoetis’s dividend payout ratio (DPR) is presently 36.56%.

Insider Activity

In other news, Director Willie M. Reed sold 1,210 shares of Zoetis stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $166.14, for a total value of $201,029.40. Following the completion of the transaction, the director now owns 11,245 shares of the company’s stock, valued at $1,868,244.30. This trade represents a 9.71 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Roxanne Lagano sold 326 shares of Zoetis stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $170.00, for a total transaction of $55,420.00. Following the completion of the transaction, the executive vice president now directly owns 15,781 shares of the company’s stock, valued at approximately $2,682,770. This trade represents a 2.02 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,862 shares of company stock valued at $312,254 in the last quarter. Company insiders own 0.16% of the company’s stock.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.